Stock listing

TPEx:6572 PlexBio Co., Ltd. (博錸) 股價

Follow PlexBio Co., Ltd. into a list and get an email when it puts out news.

Share price · TPEX:6572

$5.02 TWD -0.75 (-13.0%)

Close on Nov 20, 2026

This year -44.5% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.76 – $5.18 TWDNov 20, 2026
Volume
243,683 sharesNov 20, 2026
Market cap
$520.3M TWDAt the close on Nov 20, 2026 · price × 103.6M shares outstanding
Traded on an average day
$1.23M TWDMedian day 83,848 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
PlexBio Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6572 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.02-0.75-13.0%$5.18$5.18$4.76243,683
$5.77-0.27-4.5%$6.05$6.05$5.50101,070
$6.040.000.0%$6.04$6.04$5.836,743
$6.04-0.24-3.8%$6.28$6.28$5.77157,383
$6.280.000.0%$5.98$6.28$5.9820,325
$6.280.000.0%$6.28$6.28$5.9925,749
$6.28+0.32+5.4%$6.08$6.28$5.9823,166
$5.96-0.51-7.9%$6.47$6.47$5.9637,351
$6.47+0.39+6.4%$6.10$6.47$6.1027,883
$6.08+0.28+4.8%$5.42$6.08$5.20120,883
$5.80-0.25-4.1%$6.31$6.31$5.52269,275
$6.05-0.25-4.0%$6.30$6.31$5.82191,315
$6.30+0.08+1.3%$6.50$6.52$6.00278,581
$6.22-0.13-2.0%$6.50$6.50$6.2244,123
$6.35-0.34-5.1%$6.69$6.69$6.21224,970
$6.69-0.10-1.5%$6.79$6.79$6.3761,637
$6.79+0.09+1.3%$6.70$6.79$6.47106,268
$6.70-0.14-2.0%$6.52$6.85$6.51104,677
$6.84+0.32+4.9%$6.84$6.84$6.840
$6.52-0.35-5.1%$6.87$6.97$6.5265,154
$6.87+0.05+0.7%$6.92$6.92$6.5936,261
$6.82-0.30-4.2%$7.12$7.14$6.5775,710
$7.12+0.13+1.9%$6.99$7.12$6.6083,265
$6.99-0.05-0.7%$6.91$6.99$6.6512,221
$7.04-0.10-1.4%$6.81$7.05$6.70135,110
$7.14+0.09+1.3%$7.14$7.14$6.8126,856
$7.05-0.09-1.3%$6.81$7.14$6.6475,045
$7.14-0.53-6.9%$7.57$7.57$6.45279,708
$7.67+0.65+9.3%$7.09$8.02$7.07404,828
$7.02+0.01+0.1%$7.30$7.30$6.9888,414
$7.01-0.30-4.1%$7.31$7.31$6.9789,471
$7.31+0.33+4.7%$6.98$7.31$6.89170,374
$6.980.000.0%$6.95$6.98$6.89126,488
$6.98-0.01-0.1%$7.00$7.18$6.85107,264
$6.99-0.12-1.7%$6.78$7.03$6.78100,389
$7.110.000.0%$7.11$7.11$6.7869,679
$7.11+0.02+0.3%$7.09$7.11$6.78148,132
$7.09+0.21+3.1%$7.00$7.10$6.8377,200
$6.88+0.07+1.0%$7.00$7.14$6.8180,527
$6.81-0.46-6.3%$7.28$7.28$6.7549,766
$7.270.000.0%$7.02$7.27$6.9241,874
$7.270.000.0%$7.27$7.27$6.9384,430
$7.27+0.30+4.3%$7.22$7.27$6.9318,979
$6.97-0.10-1.4%$6.76$7.25$6.7669,081
$7.07-0.22-3.0%$7.29$7.35$6.76144,194
$7.29+0.09+1.2%$7.18$7.53$6.85269,848
$7.20-1.29-15.2%$8.50$8.50$6.711,386,169
$8.490.000.0%$8.47$10.70$8.082,357,909
$8.49+0.99+13.2%$7.25$8.83$7.23531,121
$7.50-0.17-2.2%$7.31$7.70$7.3048,052
$7.67-0.03-0.4%$7.89$7.89$7.09120,750
$7.70+0.08+1.0%$8.01$8.01$7.57156,747
$7.62-0.46-5.7%$8.02$8.03$7.6150,345
$8.08-0.01-0.1%$8.08$8.09$7.7131,233
$8.09+0.26+3.3%$7.82$8.40$7.5036,993
$7.83-0.02-0.3%$7.52$7.85$7.4849,741
$7.85+0.04+0.5%$7.81$8.09$7.4087,622
$7.81+0.13+1.7%$7.78$7.81$7.6136,306
$7.68+0.01+0.1%$7.66$7.68$7.3127,213
$7.67-0.05-0.6%$7.86$7.87$7.1457,402
$7.72-0.01-0.1%$7.41$8.02$7.41191,658
$7.73-0.10-1.3%$7.84$8.21$7.60154,436
Ticker
TPEx:6572
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
TPEx
Currency
TWD

PlexBio Co., Ltd. on 6ix

Sector
Health care
Industry
Diagnostics & research services

Valuation

EV/sales 1.9× against a median of 3.6×: 5th lowest of 10 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$237.1M TWD
P/E
Loss
EV/sales
1.9×
EV/EBITDA
Negative EBITDA
Price/book
1.8×
Gross margin
31.8%
Operating margin
−51.6%
Net margin
−49.1%
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PlexBio Co., Ltd. · TPEX:6572US$15.79MUS$7.19Mn/a1.9×n/a1.8×−49.1%0.0×n/a
Nexsen Limited · ASX:NXNUS$18.05MUS$15.08Mn/an/an/a4.8×n/a0.0×n/a
Genedrive PLC · LSE:GDRUS$17.85MUS$18.00Mn/a18.0×n/an/a−684.7%n/an/a
Microba Life Sciences Limited · ASX:MAPUS$17.70MUS$15.16Mn/a1.6×n/a1.1×−140.4%0.2×n/a
Biosynex SA · EURONEXT:ALBIOUS$15.37MUS$73.75Mn/a0.7×2.3×0.4×−61.1%1.9×n/a
Verici DX PLC · LSE:VRCIUS$15.25MUS$13.61Mn/a3.6×n/a2.6×−189.2%0.1×n/a
Medicon Hellas · ATHEX:MEDICUS$14.99MUS$7.66M7.7×0.4×1.9×0.7×9.8%0.0×n/a
Pharmigene, Inc. · TPEX:7595US$14.70MUS$29.38Mn/a4.8×n/a1.9×−36.5%2.2×n/a
BCAL Diagnostics Limited · ASX:BDXUS$14.64MUS$18.17Mn/a150×n/an/an/an/an/a
Rhythm Biosciences Limited · ASX:RHYUS$14.05MUS$11.94Mn/a211×n/a5.8×n/a0.1×n/a
Noul Co Ltd. · KRX:376930US$14.03MUS$6.23Mn/a1.6×n/a1.1×−389.6%0.0×n/a
Median of the othersUS$15.12MUS$15.12M7.7×3.6×2.0×1.5×−140.4%0.1×

Team and board

Officers

OfficerRole
Lipi YehCFO
Dean TsaoChairman/President
Jason LeiSenior Vice President of Research & Development

Board

DirectorRole
Dean TsaoChairman/President

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue127.1M128.1M167.2M191.2M124.9M101.3M
Cost of revenue86.7M78.8M104.7M132.2M86.4M59.7M
Gross profit40.4M49.3M62.5M59.0M38.6M41.7M
Research and development52.5M69.3M63.0M72.6M113.3M113.4M
Selling, general and administrative53.6M39.3M38.7M37.4M40.5M44.2M
Operating income-65.6M-79.5M-64.2M-66.9M-135.3M-148.3M
Depreciation and amortization16.5M18.8M18.0M20.1M24.5M25.3M
EBITDA-49.2M-60.8M-46.2M-46.9M-110.7M-123.0M
Interest expense265.0K164.0K263.0K167.0K226.0K234.0K386.0K
Income before tax-62.5M-61.6M-58.5M-53.1M-131.6M-141.1M
Net income-62.5M-61.6M-58.5M-53.1M-131.6M-141.1M
Earnings per share, basic-0.60-0.59-0.56-0.51-1.27-1.37

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents191.0M266.5M278.9M310.4M348.3M315.5M
Short-term investments137.4M149.0M149.0M169.0M213.5M350.7M
Receivables1.39M3.98M537.0K2.20M5.32M9.54M20.2M
Inventory50.3M37.3M30.3M37.6M50.3M42.7M
Current assets416.9M536.3M478.6M547.9M684.9M771.3M
Total assets446.6M572.4M516.7M582.2M732.8M823.2M
Accounts payable3.08M9.86M2.46M2.77M3.26M9.11M4.59M
Current liabilities116.6M168.9M54.5M46.3M144.6M93.4M
Total debt5.67M10.9M6.02M9.15M9.49M494.0K
Total liabilities136.1M198.0M92.3M102.7M198.5M160.7M
Shareholders' equity310.4M374.4M424.4M479.4M534.3M662.5M
Shares outstanding103.6M104.5M104.5M103.6M103.5M103.0M79.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-79.1M-5.06M-29.3M-71.4M-84.3M-110.8M
Capital spending-413.0K-3.59M-3.07M-2.02M-11.6M-6.49M0
Free cash flow-79.5M-8.64M-32.3M-73.5M-95.9M-117.3M
Cash from investing809.0K16.9M42.1M126.3M-24.1M
Cash from financing-8.66M-19.0M-8.88M-8.91M3.35M
Change in cash-75.5M-12.3M-31.5M-37.9M32.8M-131.1M

Open Financials

Cap table

Built by 6ix from PlexBio Co., Ltd.’s releases

Common shares
103,649,000
Fully diluted
103,649,000

Fully diluted

LineShares
Common shares103,649,000

Share count over time

CountShares
Nov 22, 2026103,649,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
日商電化株式會社36.1M34.8%Oct 31, 2026
美商DPT Biofund LLC12.2M11.8%Oct 31, 2026
曹汀4.23M4.1%Oct 31, 2026
王淮00.00%Oct 31, 2026
曹德風00.00%Oct 31, 2026
大橋保宏00.00%Oct 31, 2026
陳朝裕00.00%Oct 31, 2026
洪嘉宏00.00%Oct 31, 2026
李德政00.00%Oct 31, 2026
雷志賢00.00%Oct 31, 2026
All 13 holders
HolderSharesOf the companyAs of
葉麗碧00.00%Oct 31, 2026
陳銘德00.00%Oct 31, 2026
Peter C Luu00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dean TsaoChairman/President · Since at least Nov 5, 2026
Jason LeiSenior Vice President of Research & Development · Since at least Nov 5, 2026
Lipi YehCFO · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about PlexBio Co., Ltd.